Cost analysis of different brands of antianginal drugs available in India

Akila, Lakshmanan; Rani, Raj

doi:10.18203/2319-2003.ijbcp20150856

Cited by 13 publications

(14 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…15 Cost related poor medication adherence has been found to be related to adverse health outcomes. 16 In India, there are many pharmaceutical companies which sell a particular drug under different brand names along with the innovator company. There are large numbers of formulations for the same drugs are available leading to large variation in the price of drugs leading to an unnecessary economic burden on Indian population.…”

Section: Discussionmentioning

confidence: 99%

Cost variation analysis of ACE inhibitors in India

Wadagbalkar

Patel

Raipurkar

2017

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

Background: Cardiovascular diseases are the most prevalent cause of death and disability in developed and developing countries. There is a wide variation in the prices of antihypertensive drugs marketed in India. Thus, a study was planned to find out variation in cost in the ACE Inhibitors available in India either as a single drug or in combination and to evaluate the difference in cost of various brands of the same ACE Inhibitors and ARBs by calculating percentage variation in cost in Indian rupees.Methods: Minimum and maximum costs in rupees (INR) of antihypertensive agents manufactured by different companies, in the same strength and dosage forms were obtained from “current index of medical specialties” January April 2016 and Drug Today October-December 2016. The cost ratio and percentage cost variation were calculated for each generic antihypertensive agent (ACE Inhibitors and ARBs).Results: This study shows that there is a wide variation in the prices of different brands of same ACE Inhibitors and ARBs in Indian market.Highest cost variation 400% is for Lisinopril (2.5mg), followed by Enalapril (10mg) 394.16%, Telmisartan (20mg) 322.22%.Conclusions: There is a wide difference in the cost of different brands of ACE Inhibitors and ARBs available in India. They have important role in management of hypertension particularly if associated with other morbidities like diabetes. The clinicians prescribing these drugs should be aware of these variations in cost so as to reduce the cost of drug therapy and increase the patient adherence to the therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Cost variation analysis of ACE inhibitors in India

Wadagbalkar

Patel

Raipurkar

2017

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

show abstract

“…Similar findings have been reported from different studies conducted in India. 6,13,20 The cost difference calculated in this study was for a course of drug sufficient for a maximum period of one month. The cost variation assumes more significance in chronic diseases like asthma, which require prolonged treatment.…”

Section: Discussionmentioning

confidence: 99%

A calm look at the cost of various brands of antiasthmatic drugs available in India

Mir

2016

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

“…From this we can deduce that how many times costliest brand costs more than the cheapest brand in each generic group. Highest number of brands of antipsychotic drug available in Indian market are for divalproex sodium 500 mg (25) followed by olanzapine 15 mg(23), olanzapine 5 mg(23), olanzapine 2.5 mg (14), and risperidone 1 mg (14). Highest numbers of formulations of antipsychotic drug available in Indian market are for olanzapine(06), quetiapine(05), haloperidol(05), and aripiprazole(05) ( Table 2).…”

Section: Methodsmentioning

confidence: 99%

Cost analysis of antipsychotic drugs available in India

Shukla

Agnihotri²

2017

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

Background: Indian drug market has large numbers of branded formulations for every drug molecule. 1 Cost-sensitive healthcare environment has created a challenging workplace for clinicians. Efficient use of healthcare resources without compromising quality of patient care has been a challenging task for healthcare professionals. There is a wide range of variation in the prices of drugs marketed in India. Thus, a study was planned to analyse out cost variations of antiepileptic drugs available in Indian market.Methods: Minimum and maximum costs in Rupees (INR) of different brands of same generic antipsychotic drugs, in the same strength and dosage forms were compared. The cost ratio and percentage cost variation were calculated for each generic antipsychotic drug. The number of formulations for antipsychotic drugs and number of brands for each of them were also taken into consideration.Results: This study shows that in Indian market, there are wide variations in the prices of different brands of same generic antipsychotic drug. The highest cost ratio and percent cost variation was found for risperidone 2 mg [(1:16.27) and 1527.48], followed by risperidone 4 mg [(1:16.25) and 1525.25], risperidone 3 mg [(1:15.67) and 1467.33], risperidone 1 mg [(1:14.86) and 1386.78], olanzapine 10 mg [(1:12.36) and 1136.84], and olanzapine 5 mg [(1:12.31) and 1130.76]. Highest number of brands of antipsychotic drug available in Indian market are for divalproex sodium 500mg(25) followed by olanzapine 15 mg(23), olanzapine 5 mg(23), olanzapine 2.5mg(14), and risperidone 1 mg (14). Highest numbers of formulations of antipsychotic drug available in Indian market are for olanzapine(06), quetiapine(05), haloperidol(05), and aripiprazole(05).Conclusions: In Indian market, the average percentage price variation of different brands of the same oral antipsychotic drugs is very wide. Treatment with antipsychotic drugs usually has a long course with treatment adherence being a crucial factor for successful treatment. Improved adherence to the drug treatment can be ensured by decreasing the cost of therapy. Decreased drug cost expenditure can be ensured by changes in the government policies and regulations, integrating pharmacoeconomics as part of medical education curriculum, and creating awareness among treating physicians for switching to cost effective therapy.

show abstract

Cost analysis of different brands of antianginal drugs available in India

Cited by 13 publications

References 8 publications

Cost variation analysis of ACE inhibitors in India

Cost variation analysis of ACE inhibitors in India

A calm look at the cost of various brands of antiasthmatic drugs available in India

Cost analysis of antipsychotic drugs available in India

Contact Info

Product

Resources

About